UA75369C2 - Phenoxyphenyl alkane sulfonates, a method for the preparation thereof and medicament based thereon - Google Patents
Phenoxyphenyl alkane sulfonates, a method for the preparation thereof and medicament based thereon Download PDFInfo
- Publication number
- UA75369C2 UA75369C2 UA2003043896A UA2003043896A UA75369C2 UA 75369 C2 UA75369 C2 UA 75369C2 UA 2003043896 A UA2003043896 A UA 2003043896A UA 2003043896 A UA2003043896 A UA 2003043896A UA 75369 C2 UA75369 C2 UA 75369C2
- Authority
- UA
- Ukraine
- Prior art keywords
- group
- compounds
- compounds according
- trifluoromethyl
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/20—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
- C07C309/22—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10047486A DE10047486A1 (de) | 2000-09-26 | 2000-09-26 | Phenoxyphenyl Alkansulfonate |
| PCT/EP2001/010564 WO2002026702A1 (de) | 2000-09-26 | 2001-09-13 | Phenoxyphenyl alkansulfonate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA75369C2 true UA75369C2 (en) | 2006-04-17 |
Family
ID=7657564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2003043896A UA75369C2 (en) | 2000-09-26 | 2001-09-13 | Phenoxyphenyl alkane sulfonates, a method for the preparation thereof and medicament based thereon |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6756409B2 (no) |
| EP (1) | EP1334086B1 (no) |
| JP (1) | JP2004509946A (no) |
| KR (1) | KR20030039372A (no) |
| CN (1) | CN1476427A (no) |
| AR (1) | AR033575A1 (no) |
| AT (1) | ATE292621T1 (no) |
| AU (2) | AU2002220547B2 (no) |
| BG (1) | BG107634A (no) |
| BR (1) | BR0114182A (no) |
| CA (1) | CA2423171A1 (no) |
| DE (2) | DE10047486A1 (no) |
| EE (1) | EE200300117A (no) |
| ES (1) | ES2240543T3 (no) |
| GT (1) | GT200100193A (no) |
| HN (1) | HN2001000214A (no) |
| HR (1) | HRP20030326A2 (no) |
| HU (1) | HUP0302258A3 (no) |
| IL (1) | IL154968A0 (no) |
| MA (1) | MA26053A1 (no) |
| MX (1) | MXPA03002546A (no) |
| NO (1) | NO20031357D0 (no) |
| NZ (1) | NZ524886A (no) |
| PE (1) | PE20020408A1 (no) |
| PL (1) | PL361015A1 (no) |
| PT (1) | PT1334086E (no) |
| RU (1) | RU2278853C2 (no) |
| SI (1) | SI1334086T1 (no) |
| SK (1) | SK3442003A3 (no) |
| SV (1) | SV2002000639A (no) |
| UA (1) | UA75369C2 (no) |
| UY (1) | UY26945A1 (no) |
| WO (1) | WO2002026702A1 (no) |
| ZA (1) | ZA200302275B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003061699A1 (en) * | 2001-12-27 | 2003-07-31 | Japan Tobacco, Inc. | Remedies for allergic diseases |
| WO2003075917A1 (en) | 2002-03-08 | 2003-09-18 | Signal Pharmaceuticals, Inc. | Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| CN102149379A (zh) | 2008-07-10 | 2011-08-10 | 安吉翁生物医药有限公司 | 调节肝细胞生长因子(分散因子)活性的方法和肝细胞生长因子(分散因子)活性的小分子调节剂组合物 |
| US10709497B2 (en) * | 2017-09-22 | 2020-07-14 | Covidien Lp | Electrosurgical tissue sealing device with non-stick coating |
| EP3927702A4 (en) | 2019-04-11 | 2022-05-11 | Angion Biomedica Corp. | SOLID FORMS OF (E)-3-[2-(2-THIENYL)VINYL]-1H-PYRAZOLE |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE216642C (no) * | ||||
| BE786644A (fr) * | 1971-07-23 | 1973-01-24 | Hoechst Ag | Derives d'acides phenoxy-4 phenoxy-alcane-carboxyliques leur preparation et les medicaments qui en contiennent |
| US3914418A (en) * | 1971-09-02 | 1975-10-21 | Merck & Co Inc | Methods of controlling liver fluke infections |
| GB8914660D0 (en) * | 1989-06-26 | 1989-08-16 | Fujisawa Pharmaceutical Co | Aniline derivatives,processes for production thereof and pharmaceutical compositions comprising the same |
| MY117939A (en) * | 1996-07-25 | 2004-08-30 | Lg Chemical Ltd | Composition for enhancing oral hygiene |
| US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
| AU735137B2 (en) * | 1997-02-21 | 2001-07-05 | Bayer Intellectual Property Gmbh | Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders |
| US5925654A (en) * | 1997-03-12 | 1999-07-20 | G.D. Searle & Co. | LTA4 , hydrolase inhibitors |
| DK1031556T3 (da) * | 1997-10-20 | 2003-02-24 | Taisho Pharmaceutical Co Ltd | 2-phenoxyanilinderivater |
| US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| NL1008795C2 (nl) * | 1998-04-02 | 1999-10-05 | Rene Werenfridus Lodewijk Vroo | Samenstelling voor het behandelen van hoeven en werkwijze voor het vervaardigen van de samenstelling. |
| DE19837627A1 (de) * | 1998-08-19 | 2000-02-24 | Bayer Ag | Neue Aminosäureester von Arylsulfonamiden und Analoga |
| HN1998000027A (es) * | 1998-08-19 | 1999-06-02 | Bayer Ip Gmbh | Arilsulfonamidas y analagos |
| US6242422B1 (en) * | 1998-10-22 | 2001-06-05 | Idun Pharmacueticals, Inc. | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
-
2000
- 2000-09-26 DE DE10047486A patent/DE10047486A1/de not_active Withdrawn
-
2001
- 2001-09-13 HU HU0302258A patent/HUP0302258A3/hu unknown
- 2001-09-13 HR HR20030326A patent/HRP20030326A2/hr not_active Application Discontinuation
- 2001-09-13 AT AT01985700T patent/ATE292621T1/de not_active IP Right Cessation
- 2001-09-13 RU RU2003112454/04A patent/RU2278853C2/ru not_active IP Right Cessation
- 2001-09-13 BR BR0114182-1A patent/BR0114182A/pt not_active IP Right Cessation
- 2001-09-13 UA UA2003043896A patent/UA75369C2/uk unknown
- 2001-09-13 CN CNA01819527XA patent/CN1476427A/zh active Pending
- 2001-09-13 SI SI200130356T patent/SI1334086T1/xx unknown
- 2001-09-13 CA CA002423171A patent/CA2423171A1/en not_active Abandoned
- 2001-09-13 KR KR10-2003-7003902A patent/KR20030039372A/ko not_active Ceased
- 2001-09-13 DE DE50105857T patent/DE50105857D1/de not_active Expired - Fee Related
- 2001-09-13 PT PT01985700T patent/PT1334086E/pt unknown
- 2001-09-13 SK SK344-2003A patent/SK3442003A3/sk unknown
- 2001-09-13 PL PL01361015A patent/PL361015A1/xx not_active Application Discontinuation
- 2001-09-13 AU AU2002220547A patent/AU2002220547B2/en not_active Ceased
- 2001-09-13 JP JP2002531088A patent/JP2004509946A/ja active Pending
- 2001-09-13 EP EP01985700A patent/EP1334086B1/de not_active Expired - Lifetime
- 2001-09-13 MX MXPA03002546A patent/MXPA03002546A/es active IP Right Grant
- 2001-09-13 AU AU2054702A patent/AU2054702A/xx active Pending
- 2001-09-13 ES ES01985700T patent/ES2240543T3/es not_active Expired - Lifetime
- 2001-09-13 NZ NZ524886A patent/NZ524886A/en unknown
- 2001-09-13 WO PCT/EP2001/010564 patent/WO2002026702A1/de not_active Ceased
- 2001-09-13 IL IL15496801A patent/IL154968A0/xx unknown
- 2001-09-13 EE EEP200300117A patent/EE200300117A/xx unknown
- 2001-09-24 AR ARP010104486A patent/AR033575A1/es not_active Application Discontinuation
- 2001-09-24 GT GT200100193A patent/GT200100193A/es unknown
- 2001-09-24 UY UY26945A patent/UY26945A1/es not_active Application Discontinuation
- 2001-09-25 SV SV2001000639A patent/SV2002000639A/es unknown
- 2001-09-25 HN HN2001000214A patent/HN2001000214A/es unknown
- 2001-09-25 PE PE2001000958A patent/PE20020408A1/es not_active Application Discontinuation
- 2001-09-26 US US09/965,708 patent/US6756409B2/en not_active Expired - Fee Related
-
2003
- 2003-03-13 BG BG107634A patent/BG107634A/bg unknown
- 2003-03-24 ZA ZA200302275A patent/ZA200302275B/en unknown
- 2003-03-25 NO NO20031357A patent/NO20031357D0/no not_active Application Discontinuation
- 2003-03-25 MA MA27075A patent/MA26053A1/fr unknown
-
2004
- 2004-05-20 US US10/850,507 patent/US20040214886A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI233436B (en) | Benzoxazinones in combination with other agents as inhibitors of HIV reverse transcriptase | |
| JP2020186242A (ja) | フッ化硫黄(vi)化合物およびそれの製造方法 | |
| JP5302398B2 (ja) | 置換アミノテトラリン | |
| TW202204323A (zh) | 經取代之嗒𠯤化合物 | |
| US8389538B2 (en) | Rexinoid compound having alkoxy group | |
| JP2001525406A (ja) | 新規な化合物 | |
| KR20050044657A (ko) | mGluR5 안타고니스트 활성을 갖는 아세틸렌 유도체 | |
| JPH11503116A (ja) | 二環式アミン誘導体および抗精神病薬としてのそれらの使用 | |
| US8791106B2 (en) | Fused ring pyridine compound | |
| TW201116281A (en) | N atom containing ring acylguanidine derivatives | |
| AU2020256301A1 (en) | Fused bicyclic compounds for the treatment of disease | |
| KR20130094311A (ko) | P2x4 수용체 길항제 | |
| US20180065936A1 (en) | Therapeutic compounds | |
| UA75369C2 (en) | Phenoxyphenyl alkane sulfonates, a method for the preparation thereof and medicament based thereon | |
| JP2011506551A (ja) | Ampa受容体増強化合物および医薬におけるその使用 | |
| CN116655557B (zh) | 苯并噻唑类化合物、其制备方法及应用 | |
| US12297193B2 (en) | PTPN2/PTP1B degrader and therapeutic method thereof | |
| JPS63165362A (ja) | 置換アミノチメル−5,6,7,8−テトラヒドロナフチルオキシ酢酸類、中間体類、それらの製造法および薬物におけるそれらの使用 | |
| US20090170902A1 (en) | Compounds which potentiate glutamate receptor and uses thereof in medicine | |
| JP3110049B2 (ja) | 新規イミダゾールリポキシゲナーゼ阻害剤 | |
| JPH08134030A (ja) | ベンゾシクロアルケン類、その製造法および剤 | |
| WO2026026968A1 (zh) | 一种含芳香稠环的化合物、其药物组合物和应用 | |
| CN118420529A (zh) | 新型雌激素受体下调剂化合物、制备方法及用途 | |
| US20210363109A1 (en) | Phenyl cyclohexanone derivatives and methods of making and using them | |
| JPH054986A (ja) | ピラゾロキノリン誘導体 |